Charting the “unknown unknowns” of cancer progression

Article Tools

• Email

  Thank you for your interest in spreading the word about Science Translational Medicine.

  NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

  Your Email

  Your Name

  Send To

  Enter multiple addresses on separate lines or separate them with commas.

  You are going to email the following Charting the “unknown unknowns” of cancer progression

  Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

  Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

  Your Personal Message

  Send Message
• Download Powerpoint
• Print
• Save to my folders

  User Name

  Password

  Remember my user name & password.

  Submit
• Alerts

  Please log in to add an alert for this article.

  Username Enter your Sciencemag.org username.

  Password Enter the password that accompanies your username.

  Log in
• Citation tools

  Charting the “unknown unknowns” of cancer progression

  By Hani Goodarzi

  Science Translational Medicine26 Jul 2017

  Integrated computational and experimental strategies reveal previously unknown regulatory programs underlying metastatic disease.

  Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
• Share

  Charting the “unknown unknowns” of cancer progression

  By Hani Goodarzi

  Science Translational Medicine26 Jul 2017

  Integrated computational and experimental strategies reveal previously unknown regulatory programs underlying metastatic disease.

  Permalink: Copy